Cancer Gene Therapy Industry 2017: Outlook Applications, Types and Analysis including Growth, Trends and Forecasts to 2021
Research analysts forecast the Global Cancer Gene Therapy Market to grow at a CAGR of 20.63% during the period 2017-2021.
(EMAILWIRE.COM, August 15, 2017 ) Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual's body. It can be used for both the prevention and treatment of disease. The major therapies used for the treatment are oncolytic virotherapy, gene transfer, and gene-induced immunotherapy. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses.
Request sample copy of the report at: http://www.orbisresearch.com/contacts/request-sample/379321
The report covers the present scenario and the growth prospects of the global cancer gene therapy market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Research report, Global Cancer Gene Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Adaptimmune
bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Other prominent vendors
Altor BioScience
Amgen
argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market driver
Rising geriatric population
For a full, detailed list, view our report
Market challenge
High cost of gene therapy treatment
For a full, detailed list, view our report
Market trend
Favorable government regulations for gene therapy programs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Companies Mentioned:
Adaptimmune, bluebird bio, Celgene, Shanghai Sunway Biotech, Shenzhen SiBiono GeneTech, SynerGene Therapeutics, Altor BioScience, Amgen, argenx, BioCancell, GlaxoSmithKline, Merck, OncoGenex Pharmaceuticals, and Transgene.
Enquire more details of the report at: http://www.orbisresearch.com/contact/purchase/379321
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Request sample copy of the report at: http://www.orbisresearch.com/contacts/request-sample/379321
The report covers the present scenario and the growth prospects of the global cancer gene therapy market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Research report, Global Cancer Gene Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Adaptimmune
bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Other prominent vendors
Altor BioScience
Amgen
argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market driver
Rising geriatric population
For a full, detailed list, view our report
Market challenge
High cost of gene therapy treatment
For a full, detailed list, view our report
Market trend
Favorable government regulations for gene therapy programs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Companies Mentioned:
Adaptimmune, bluebird bio, Celgene, Shanghai Sunway Biotech, Shenzhen SiBiono GeneTech, SynerGene Therapeutics, Altor BioScience, Amgen, argenx, BioCancell, GlaxoSmithKline, Merck, OncoGenex Pharmaceuticals, and Transgene.
Enquire more details of the report at: http://www.orbisresearch.com/contact/purchase/379321
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results